Structural aspects of molecular dissymmetry

Polymorphism in Pharmaceutical Solids: Second Edition

Volumn , Issue , 2016, Pages 560-586

  Brittain, Harry G ^a  

^a Center for Pharmaceutical Physics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85030493257     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (66)

1. Brittain HG. Crystallographic consequences of molecular dissymmetry. Pharm Res 1990; 7: 683-90.
2. Wainer IW, Drayer DE. Drug Stereochemistry: Analytical Methods and Pharmacology. New York: Marcel Dekker, 1988.
3. Testa B, Trager WF. Racemates versus enantiomers in drug development. Chirality 1990; 2: 129-33.
4. Li ZJ, Grant DJW. Relationship between physical properties and crystal structures of chiral drugs. J Pharm Sci 1997; 86: 1073-8.
5. Fassihi AR. Racemates and enantiomers in drug development. Int J Pharm 1993; 92: 1-14.
6. Smith RL, Caldwell J. Racemates: towards a new year resolution. Trends Pharmacol Sci 1988; 9: 75-7.
7. De Camp WH. The FDA perspective on the development of stereoisomers. Chirality 1989; 1: 2-6.
8. Newman P. Optical Resolution Procedures for Chemical Compounds, Volumes 1-3. New York: Manhattan College Press, 1984.
9. Cahn RS, Ingold CK, Prelog V. Specification of molecular chirality. Angew Chem Int Ed Engl 1966; 5: 385-415.
10. Jacques J, Collet A, Wilen SH. Enantiomers, Racemates, and Resolutions. New York: John Wiley & Sons, 1981.
11. Zorkii PM, Razumaeva AE, Belsky VK. The systematization of molecular crystal structures. Acta Cryst 1977; A33: 1001-4.
12. Mason SF. Molecular Optical Activity and the Chiral Discriminations. Cambridge: Cambridge University Press, 1982: 165-6.
13. Kitaigorodskii AI. Molecular Crystals and Molecules. New York: Academic Press, 1973.
14. Wallach G. Annalen 1895; 286: 140.
15. Brock CP, Schweizer WB, Dunitz JD. On the validity of Wallach's rule: on the density and stability of racemic crystals compared with their chiral counterparts. J Am Chem Soc 1991; 113: 9811-20.
16. Walden P. Chem Ber 1896; 29: 1692.
17. Lowry TM. Optical Rotatory Power. London: Longmans, Green, & Co, 1935: 25-36.
18. Dana ES, Ford WE. A Textbook of Mineralogy. New York: John Wiley & Sons, 1922: 470.
19. Bragg WH, Gibbs RE. The structure of a and ß quartz. Proc Roy Soc 1925; A109: 405-27.
20. Wyckoff RWG. Am J Sci 1926; 11: 101.
21. Frondel C. The System of Mineralogy, Volume III. New York: John Wiley & Sons, 1962: 75-98.
22. The Merck Index, 14th ed. In: O'Neil MJ, Heckelman PE, Koch CB, Roman KJ, eds. Rahway, NJ: Merck & Co. Inc., 2006: 9069.
23. Klyne W, Buckingham J. Atlas of Stereochemistry, 2nd ed. New York: Oxford University Press, 1978: 6.
24. Stern F, Beevers CA. The crystal structure of tartaric acid. Acta Cryst 1950; 3: 341-6.
25. Okaya Y, Stemple RR, Kay MI. Refinement of the structure of D-tartaric acid by X-ray and neutron diffraction. Acta Cryst 1966; 21: 237-43.
26. Parry GS. The crystal structure of hydrate racemic acid. Acta Cryst 1951; 4: 131-8.
27. Bootsma GA, Schoone JC. Crystal structures of mesotartaric acid. Acta Cryst 1967; 22: 522-32.
28. Brozek Z, Stadnicka K. Structure of sodium ammonium (+)-tartrate tetrahydrate at 200, 151 and 120 K. Acta Cryst 1994; B50: 59-68.
29. van Bommel AJ, Bijvoet JM. The crystal structure of ammonium hydrogen D-tartrate. Acta Cryst 1958; 11: 61-70.
30. Kubozone Y, Hirano A, Nagasawa S, Maeda H, Kashino S. Structures of sodium hydrogen L-tartrate monohydrate and potassium hydrogen L-tartrate. Bull Chem Soc Jap 1993; 66: 2166-73.
31. Templeton LK, Templeton DH. Structure of rubidium hydrogen (+)-tartrate. Acta Cryst 1989; C45: 675-6.
32. Collet A, Brienne M-J, Jacques J. Optical resolution by direct crystallization of enantiomer mixtures. Chem Rev 1980; 80: 215-30.
33. Zaugg HE. A mechanical resolution of DL-methadone base. J Am Chem Soc 1955; 77: 910.
34. Brugidou J, Christol H, Sales R. Bull Soc Chim France 1974: 2033.
35. Amiard G. Sur le dedoublement direct de la threonine, par entrainement. Bull Soc Chim France 1956: 447-51.
36. Collet A, Brienne M-J, Jacques J. Dédoublements spontanés et conglomérats d'énantiomères. Bull Soc Chim France 1972: 127-42; Étude des mélanges d'antipodes optiques. XIII. Compléments à dédoublements spontanés. ibid 1977: 494-8.
37. Collet A, Jacques J. Étude des mélanges d'antipodes Optiques. V. Acides mandéliques substitués. Bull Soc Chim France 1973: 3330-4.
38. Leclercq M, Collet A, Jacques J. Étude des mélanges d'antipodes optiques. XII. Mesure de la stabilite des racemiques vrais. Tetrahedron 1976; 32: 821-8.
39. Gourlay MD, Kendrick J, Leusen FJJ. Rationalization of racemate resolution: predicting spon taneous resolution through crystal structure prediction. Cryst Growth Des 2007; 7: 56-63.
40. Lajzerowicz-Bonneteau J, Lajzerowicz J, Bordeaux D. Phase separation: statics and dynamics in a racemic molecular solid solution. Phys Rev B 1986; 34: 6453-63.
41. Meyerhoffer W. Stereochemische Notizen. Ber Dtsch Chem Ges 1904; 37: 2604-10.
42. Jacques J, Gabard J. Étude des mélanges d'antipodes optiques. III. Diagrammes de solu bilité pour les divers types de racémiques. Bull Soc Chim France 1972: 342-50.
43. Kondepudi DK, Crook KE. Theory of conglomerate crystallization in the presence of chiral impurities. Cryst Growth Des 2005; 5: 2173-9.
44. Shiraiwa T, Ohki Y, Sado Y, Miyazaki H, Kurokawa H. Optical resolution by preferential crystallization of 4-methylpiperidinium hydrogen (RS)-phenylsuccinate. Chirality 1994; 6: 202-6.
45. Wilen SH. Resolving agents and resolutions in organic chemistry. Topics in Stereochem istry 1971; 6: 107-76.
46. Wilen SH. Tables of Resolving Agents and Optical Resolutions. South Bend, IN: University of Notre Dame Press, 1972.
47. Newman P. Optical Resolution Procedures for Chemical Compounds, in three volumes. Riverdale, NY: Optical Resolution Information Center, 1984.
48. Ugi I. Use of diastereomers avoids the ambiguities of the threo, erythro nomenclature. Z Naturforsch 1965; 20B: 405-21.
49. Shiraiwa T, Sado Y, Fujii S, Nakamura M, Kurokawa H. Optical resolution of (±)-phenylsuccinic acid by using (-)-proline as resolving agent. Bull Chem Soc Jap 1987; 60: 824-6.
50. Ingersoll AW, Babcock SH, Burns FB. Solubility relationships among optically isomeric salts. III. The mandelates and a-bromocamphor-n-sulfonates of a-phenylethyl mine and A-p-tolylethylamine. J Am Chem Soc 1933; 55: 411-16.
51. Valente EJ, Zubkowski J, Egglestron DS. Discrimination in eesolving aystems I: ephedrine-mandelic acid. Chirality 1992; 4: 494-504.
52. Valente EJ, Miller CW, Zubkowski J, Egglestron DS, Shui X. Discrimination in resolving Systems II: ephedrine-substituted mandelic acids. Chirality 1995; 7: 652-76.
53. Hiramatsu H, Okamura K, Tsujioka I, Yamada S-I, Yoshioka R. Crystal structure-solubility relationships in optical resolution by diastereomeric salt formation of DL-phenylglycine with (1S)-(+)-camphor-10-sulfonic acid. J Chem Soc Perkin Trans 2000; 2: 2121-8.
54. Yoshioka R, Ohtsuki O, Da-Te T, Okamura K, Senuma M. Optical resolution, character ization, and X-ray crystal structures of diastereomeric salts of chiral amino acids with (S)-(-)-1-phenylethanesulfonic acid. Bull Chem Soc Jap 1994; 67: 3012-20.
55. Acs M, Novotny-Bregger E, Simon K, Argay G. Structural aspects of optical resolutions. Optical resolution of (R,S)-mandelic acid. DSC and X-ray studies of the diastereoisomeric salts. J Chem Soc Perkin Trans 1992; 2: 2011-17.
56. Brianso MC. Structures atomiques et moléculaires des sels diastéréoisomères des A-phényl-a-méthylacétates d'a-phényl-éthylammonium p et n. Acta Cryst 1976; B32: 3040-5.
57. Lopez de Diego H. Crystal structure of (S)-1-phenylethylammonium (R)-mandelate and a comparison of diastereomeric mandelate salts of 1-phenylethylamine. Acta Chem Scand 1994; 48: 306-11.
58. Jacques J, Leclercq M, Brienne M-J. La formation de sels augmente-t-elle la fréquence des dédoublements spontanés. Tetrahedron 1981; 37: 1727-33.
59. Kozma D, Böcskei Z, Simon K, Fogassy E. Racemic compound formation-conglomerate formation. Part 1. Structural and thermoanalytical study of hydrogen manonate, hydrogen phthalate, and hydrogen succinate of a-phenylethylamine. J Chem Soc Perkin Trans 1994; 2, 1883-6.
60. Böcskei Z, Kassai C, Simon K, Fogassy E, Kozma D. Racemic compound formation-conglomerate formation. Part 3. Investigation of the acidic salts of a-phenylethylamine by achiral dicarboxylic acids. Optical resolution by preferential crystallization and a structural study of (R)-a-phenylethylammonium hydrogen itaconate. J Chem Soc Perkin Trans 1996; 2: 1511-15.
61. Freer AA, Bunyan JM, Shankland N, Sheen DB. Structure of (S)-(+)-ibuprofen. Acta Cryst 1993; C49: 1378-80.
62. Shankland N, Wilson CC, Florence AJ, Cox PJ. Refinement of ibuprofen at 100 K by single-crystal pulsed neutron diffraction. Acta Cryst 1997; C53: 951-4.
63. Dwivedi SK, Sattari S, Jamali F, Mitchell AG. ibuprofen racemate and enantiomers: phase diagram, solubility, and thermodynamic studies. Int J Pharm 1992; 87: 95-104.
64. Effers EJ, Plum BJ, Ariaans GJA, et al. New Resolving Bases for Ibuprofen and Mandelic Acid: Qualification by Binary Phase Diagrams. Tetrahedron: Assymmetry 1997; 8: 4047-57.
65. Prankerd RJ. Critical compilation of pKa values for pharmaceutical substances, in Profiles of Drug Substances, Excipients, and Related Methodology, volume 33. In: Brittain HG, ed. Amsterdam: Elsevier-Academic Press, 2007: 221.
66. Brittain HG. Unpublished results.